Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04585542 · ClinicalTrials.gov registry record · Phase 4
Comparison of Potassium Binders in the ER
A Phase 4 study, sponsored by University of California, Irvine.
- Terminated
- Registry status
- Phase 4
- Development phase
- 37
- Enrollment target
NCT04585542: Clinical Trial Phase 4 study, sponsored by University of California, Irvine.
NCT04585542 is a Phase 4 study that was terminated before completion, run by University of California, Irvine. The registered enrollment target is 37 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04585542, a Phase 4 study, was terminated before completion, sponsored by University of California, Irvine.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 37 participants
- Enrollment target
Study Summary
Compare efficacy of 3 oral potassium binders (cation exchange resins) on lowering blood potassium, in hospital patients with acute hyperkalemia.
Primary Outcome
The investigators will compare the change in blood potassium after administration of the study drug, in the acute setting.
Interventions
- DRUG Polyethylene Glycol 3350
- DRUG Patiromer
- DRUG Sodium zirconium cyclosilicate
- DRUG Sodium Polystyrene Sulfonate Oral Suspension [SPS]
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2020-10-20 |
| Est. Completion | 2025-01-31 |
| Phase | Phase 4 |
Why NCT04585542 stopped before completion
NCT04585542 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 4 interventions - of which Polyethylene Glycol 3350 is the first listed.
NCT04585542 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04585542 about?
NCT04585542 is a clinical study titled "Comparison of Potassium Binders in the ER". Compare efficacy of 3 oral potassium binders (cation exchange resins) on lowering blood potassium, in hospital patients with acute hyperkalemia.
What is the current status of trial NCT04585542?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 37 participants. The study started on 2020-10-20. Estimated completion is 2025-01-31.
What interventions are being tested in trial NCT04585542?
The interventions under investigation include: Polyethylene Glycol 3350 (DRUG), Patiromer (DRUG), Sodium zirconium cyclosilicate (DRUG), Sodium Polystyrene Sulfonate Oral Suspension [SPS] (DRUG).
Who is sponsoring clinical trial NCT04585542?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04585542's enrollment target sits among peer trials
37 1482nd of 2000 higher than 511 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI